Open Rank Faculty: Advanced Cell Therapy Research

C001 Medical University of South Carolina (MUSC - Univ); Town of Charleston (NY); On-site; USD 120,000 - 180,000; Full time

Job summary

Medical University of South Carolina (MUSC) invites applications for a full-time, open rank, tenure-track faculty position in advanced cellular therapy. The successful candidate will establish an independent, externally funded research program in cell therapy, stem cell biology, gene-modified therapies, or related translational work.

The ICCT at MUSC fosters collaboration across clinical and research units to translate cellular immunotherapies for autoimmune, inflammatory, neurological and other

Qualifications

• PhD, MD, or MD/PhD in cell therapy, cell biology, biomedical engineering, or a related field.
• Postdoctoral experience with a strong record of research productivity
• Evidence of or potential for securing independent funding (e.g., NIH R01, foundation grants).
• Senior applicants should demonstrate a sustained track record of high-impact research and leadership.

Responsibilities

• Develop and lead a robust independent research program related to advanced cellular therapy.
• Foster interdisciplinary collaboration across MUSC’s academic, clinical, and translational units.
• Obtain extramural funding to support research endeavors.
• Publish impactful research in peer-reviewed scientific journals.
• Participate in the training and mentorship of graduate students, postdoctoral fellows, and clinical residents.
• Contribute to the strategic growth of the ICCT’s translational and clinical research initiatives.

Skills

Leadership

Grant writing

Independent funding

Collaborative research

Education

PhD/MD/MD-PhD in cell therapy

Job description

Medical University of South Carolina (MUSC) invites applications for a full-time, open rank, tenure-track faculty position in advanced cellular therapy. The successful candidate will establish an independent, externally funded research program in cell therapy, stem cell biology, gene-modified therapies, or related translational work.

The ICCT at MUSC fosters collaboration across clinical and research units to translate cellular immunotherapies for autoimmune, inflammatory, neurological and other